Sign In
Buy INMB
$1.32
-0.1000 (-7.04%)
At Close: Jun 03, 2026
INmune Bio, Inc., an immunology company developing therapies that reprogram the patient’s innate immune system to treat diseases, today announced that it has successfully completed the Phase I tria
INmune Bio, Inc. Announces First Alzheimer’s Disease Patient Dosed in XPro1595 Study
02:00pm, Monday, 02'nd Dec 2019
LA JOLLA, Calif., Dec. 02, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (INMB), an immunology company developing treatments that harness the patient’s innate immune system to fight disease, announc
INmune Bio Inc. to Discuss Potential New Alzheimer’s Disease Treatments in CTAD Pre-Conference Webinar
11:00am, Tuesday, 26'th Nov 2019
INmune Bio’s CEO, Dr. R.J. Tesi, will moderate a panel of experts from neuroscience research, clinical trials, and Alzheimer’s drug development. Lawrence T. Friedhoff, M.D., Ph.D., who is credite
Wirecard Teams Up With NK Department Stores to Accept Chinese Mobile Payment Methods
01:02pm, Thursday, 06'th Jun 2019
Germany-based global provider of digital payments and commerce solutions Wirecard announced on Thursday it has teamed up with NK department stores to accept Ch
